This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Exelixis, Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Ariella Hanker: Innovator in Cancer Treatment
Introduction
Ariella Hanker is a prominent inventor based in Nashville, TN (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic compounds.
Latest Patents
Ariella holds a patent for "Combinations of kinase inhibitors for the treatment of cancer." This invention provides methods of treating cancer by administering a compound of formula I, optionally as a pharmaceutically acceptable salt, solvate, and/or hydrate thereof, in combination with an inhibitor that targets HER2 and/or HER3. This groundbreaking work has the potential to improve treatment outcomes for cancer patients.
Career Highlights
Throughout her career, Ariella has worked with notable companies such as Exelixis, Inc. and Sanofi. Her experience in these organizations has allowed her to develop her expertise in the pharmaceutical industry and contribute to advancements in cancer therapies.
Collaborations
Ariella has collaborated with esteemed colleagues, including Dana T Aftab and Carlos L Arteaga. These partnerships have further enriched her research and development efforts in the field of oncology.
Conclusion
Ariella Hanker is a dedicated inventor whose work in cancer treatment exemplifies innovation and collaboration. Her contributions are paving the way for new therapeutic options in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile